Want to see IN:GEMAROMA full AI Analyst Report?
GEMAROMA Stock Chart & Stats
₹175.60
--
Market closed
₹175.60
--
Day’s Range― - ―
52-Week Range₹133.10 - ₹349.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)17.80K
Market Cap
₹9.93B
Enterprise Value₹8.57K
Total Cash (Recent Filing)₹367.87M
Total Debt (Recent Filing)₹1.46B
Price to Earnings (P/E)1127.1
Beta1.85
Next Earnings
Sep 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.79
Shares Outstanding52,237,137
10 Day Avg. Volume24,364
30 Day Avg. Volume17,801
Financial Highlights & Ratios
PEG Ratio3.70
Price to Book (P/B)1.56
Price to Sales (P/S)1.92
P/FCF Ratio-9.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained 25.6% revenue growth in FY2026 indicates durable demand and successful commercial traction in core chemical products. Over a 2-6 month horizon this growth supports scale economics, provides capacity to invest in margin expansion and reduces reliance on one-off gains for recurring performance.
Improved Operating MarginsMaterial improvement in EBIT/EBITDA margins reflects better cost control or mix shift, demonstrating operational leverage. If sustained, higher operating margins create a larger buffer against volatility in raw material costs and support long-term profitability even if below-the-line costs remain elevated.
Meaningfully Lower Leverage (D/E)A sharp decline in debt-to-equity materially improves balance-sheet resilience and financial flexibility. Lower leverage reduces interest burden and refinancing pressure, enabling the company to better fund working capital or strategic investments without immediate solvency risk over the medium term.
Bears Say
Extremely Thin Net MarginA sub-0.5% net margin means most operating gains are absorbed by below-the-line items (interest, tax, exceptional costs). This offers little earnings cushion, making long-term profitability highly sensitive to cost inflation, input shocks, or modest revenue setbacks and limits sustainable shareholder returns.
Deeply Negative Free Cash FlowPersistently negative and deteriorating free cash flow signals structural cash-generation weakness. Over quarters, this forces reliance on external funding for capex and working capital, constraining organic reinvestment, raising refinancing risk, and limiting the company's ability to self-fund growth or return capital.
Sizable Absolute Debt & Funding DependenceDespite improved D/E, the company still carries significant absolute debt and shows signs of funding dependence. Combined with negative FCF, this constrains strategic flexibility, raises interest and refinancing exposure, and heightens execution risk if market access tightens or rates rise.
Gem Aromatics Limited News
GEMAROMA FAQ
What was Gem Aromatics Limited’s price range in the past 12 months?
Gem Aromatics Limited lowest stock price was ₹133.10 and its highest was ₹349.00 in the past 12 months.
What is Gem Aromatics Limited’s market cap?
Gem Aromatics Limited’s market cap is ₹9.93B.
When is Gem Aromatics Limited’s upcoming earnings report date?
Gem Aromatics Limited’s upcoming earnings report date is Sep 11, 2026 which is in 37 days.
How were Gem Aromatics Limited’s earnings last quarter?
Gem Aromatics Limited released its earnings results on May 21, 2026. The company reported ₹0.194 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Gem Aromatics Limited overvalued?
According to Wall Street analysts Gem Aromatics Limited’s price is currently Overvalued.
Does Gem Aromatics Limited pay dividends?
Gem Aromatics Limited does not currently pay dividends.
What is Gem Aromatics Limited’s EPS estimate?
Gem Aromatics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gem Aromatics Limited have?
Gem Aromatics Limited has 52,237,137 shares outstanding.
What happened to Gem Aromatics Limited’s price movement after its last earnings report?
Gem Aromatics Limited reported an EPS of ₹0.194 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.764%.
Which hedge fund is a major shareholder of Gem Aromatics Limited?
Currently, no hedge funds are holding shares in IN:GEMAROMA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Gem Aromatics Limited
Based in Mumbai, India, Gem Aromatics Limited, established in 1997, operates as a global producer and distributor of a wide array of specialized aromatic compounds. The firm's product catalog features a comprehensive selection of mint derivatives, such as peppermint, spearmint, and menthol. It also supplies clove derivatives, including clove oil, eugenol, and related compounds, alongside phenol in the form of anethole. Complementing these, Gem Aromatics offers other essential ingredients like eucalyptus, eucalyptol, and lemongrass. These versatile offerings are integral to various industries, including oral hygiene, beauty products, personal grooming, and numerous other applications, with a market presence spanning India, the United States, China, Brazil, Singapore, and other international regions.